This study aimed to evaluate the association between CCNB1 at the transcriptomic and proteomic levels and LVI status, LVI-related biomarkers and other clinicopathological parameters using large well-annotated BC cohorts with long-term follow-up. The gene discussed is CCNB1; the disease is breast cancer.